Welcome
Support Centre
21 May 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
Immune activation in chronic heart failure and the role of endotoxin
ISRCTN ISRCTN21486547
ClinicalTrials.gov identifier
Public title Immune activation in chronic heart failure and the role of endotoxin
Scientific title
Acronym N/A
Serial number at source N0201082084
Study hypothesis To investigate whether CHF is associated with immune dysregulation and to establish whether endotoxin levels are increased in heart failure patients and whether an endotoxin challenge is a component of immune activation in patients with severe CHF. Study could lead to new therapeutic insights and could contribute to the development of new therapeutic strategies for immune activation in CHF and a syndrome currently without effective treatment ie cardiac cachexia.
Lay summary
Ethics approval Not provided at time of registration
Study design Randomised controlled trial
Countries of recruitment United Kingdom
Disease/condition/study domain Cardiovascular: Chronic heart failure
Participants - inclusion criteria Not provided at time of registration
Participants - exclusion criteria Not provided at time of registration
Anticipated start date 01/04/1997
Anticipated end date 29/06/2006
Status of trial Completed
Patient information material
Target number of participants 20
Interventions Study A: Randomised Controlled Trial (10 cachetic and 10 non-cachetic stable CHF patients, and 10 controls)
Study B: Cohort Observation (10 CHF patients presenting acute oedematous exacerbation)
Primary outcome measure(s) Not provided at time of registration
Secondary outcome measure(s) Not provided at time of registration
Sources of funding Royal Brompton and Harefield NHS Trust (UK) Joint Committee for Research
Trial website
Publications
Contact name Prof  Philip A  Poole-Wilson
  Address Imperial College School of Medicine NHLI
Guy Scadding Building
Dovehouse Street
  City/town London
  Zip/Postcode SW3 6LY
  Country United Kingdom
Sponsor Record Provided by the NHSTCT Register - 2006 Update - Department of Health
  Address The Department of Health, Richmond House, 79 Whitehall
  City/town London
  Zip/Postcode SW1A 2NL
  Country United Kingdom
  Tel +44 (0)20 7307 2622
  Email dhmail@doh.gsi.org.uk
  Sponsor website: http://www.dh.gov.uk/Home/fs/en
Date applied 29/09/2006
Last edited 16/02/2010
Date ISRCTN assigned 29/09/2006
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central